The Relative Strength (RS) Rating for Manhattan Associates entered a higher percentile Monday, as it got a lift from 66 to 73.
IBD's unique RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks compares to other publicly traded companies.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves. See if Manhattan Associates can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Manhattan Associates is working on a flat base with a 307.50 entry. See if the stock can clear the breakout price in heavy trade.
The company posted 29% earnings growth last quarter. Revenue rose 12%.
Manhattan Associates earns the No. 22 rank among its peers in the Computer Software-Enterprise industry group. Samsara, ServiceNow and Palantir Technologies are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
